Scroll Up
Scroll Down
Play Play Play Play
Unregistered User
Click here if this is not your Personal Edition
 
Contact Us | Free E-Mail Updates | Journals | Register a colleague
 
 
Ovarian Cancer
 
   
 
SEARCH   
Doctor's Guide Free CME
Medline
Congress Resource Centre
 

 EXPLORE :
   Most Read News
 All News  All News
 All Webcasts / CME  All Webcasts / CME
 All Cases  All Cases
 Congress Resource Centre  Congress Resource Centre
 All Medical Resources  All Medical Resources
 Medical  My Personal Edition



Warning | Privacy

 

 
 Recent news - Ovarian Cancer
    Annual Report Finds Declines in Cancer Incidence and Death in US, But Wide Variation in Lung Cancer Trends - (DGNews)
    TopAbstracts in Ovarian Cancer 11/19/2008 - (DGNews)
    TopAbstracts in Ovarian Cancer 10/22/2008 - (DGNews)
    TopAbstracts in Ovarian Cancer 09/24/2008 - (DGNews)
    Trabectedin Produces Progression-Free Survival Benefits in Relapsed Ovarian Cancer: Presented at ESMO - (DGDispatch)

    News archive

     Recent webcasts/CME - Ovarian Cancer
    • Current Therapeutic Options and Clinical Issues in Recurrent Ovarian Cancer: Where Do We Stand?
    • Looking Ahead: Emerging Options in Treatment of Ovarian Cancer
    • Ovarian Cancer: Designed for the Primary Care Physician
      Gynecologic and Colorectal Cancer: Risks and Benefits of Contraceptive Methods

      Webcasts/CME archive

       Recent cases - Ovarian Cancer
        Ruptured Ovarian Cystic Teratoma in Pregnancy with Diffuse Peritoneal Reaction Mimicking Advanced Ovarian Malignancy: A Case Report
        Androgen Secreting Steroid Cell Tumor of the Ovary in a Young Lactating Women with Acute Onset of Severe Hyperandrogenism: A Case Report and Review of Literature
        Collision Tumor of the Colon - Colonic Adenocarcinoma and Ovarian Granulosa Cell Tumor
        Cyclophosphamide Metronomic Chemotherapy for Palliative Treatment of a Young Patient with Advanced Epithelial Ovarian Cancer
        Acute Reversible Life-Threatening Encephalopathy Following Conventional Doses of Paclitaxel Infusion

        Cases archive
          




        my personal edition > ovarian cancer > news
        divider

          E-Mail this DGDispatch to a colleague

        DGDispatch


        Increased Dietary Flavonoids May Reduce Ovarian Cancer Risk: Presented at AACR

        By Rabiya S. Tuma, PhD

        WASHINGTON, D.C. -- April 10, 2006 -- Women with the highest intake of dietary flavonoids may be at reduced risk of ovarian cancer, according to a prospective analysis from the Nurses' Health Study.

        Margaret A. Gates, a doctoral student at the Harvard School of Public Health, Boston, Massachusetts, United States, reported the results here on April 4th at the 97th Annual Meeting of the American Association for Cancer Research (AACR).

        The researchers analyzed food frequency questionnaires from 66,384 participants in the Nurses' Health Study and evaluated the association between flavonoid intake and ovarian cancer risk. Between 1984 and 2002, there were 344 ovarian cancer cases diagnosed in the population.

        Overall there was no relationship between ovarian cancer risk and flavonoids intake. However, when the team compared women in the highest and lowest quintiles for total flavonoid intake they found a significant inverse trend toward decreased ovarian cancer risk with increased intake of flavonoids (P for trend =.04). The relative risk was not significantly different for the two groups (RR=0.78, 95% CI, 0.53-1.13).

        Individual flavonoids showed different associations with risk, Ms. Gates said. For example, there was a significant risk reduction detected between the highest and lowest quintiles of kaempferol intake (RR =.66, 95% CI, 0.43-0.89, P for trend =.002). By contrast, the data suggested that myricetin (RR =.74, 95% CI, 0.51-1.06, P for trend =.01) and quercetin (RR=0.83, 95% CI, 0.57-1.21, P for trend =.06) may have a protective effect but did not reach statistical significance.

        The estimate of flavonoid intake was based on a 126-item food questionnaire that was administered at enrollment in 1984, as well as in 1990, 1994, and 1998.

        Flavonoids, occur naturally in plants and protect them from oxidative damage. Flavonoids are abundant in tea, red wine, soybeans, fruits and vegetables.

        "In the Nurses' Health Study population, the primary contributors to kaempferol intake, for which we saw the strongest association, were tea, broccoli and kale," said Ms. Gates. "Some other common foods that contain kaempferol include brussel sprouts, strawberries, grape fruit, and various types of greens." For myricetin, commonly consumed foods in the study population included tea, beans, raisins and walnuts.

        Currently there is no recommended dietary intake levels for flavonoids, commented Brian N. Fink, MPH, doctoral candidate at the University of North Carolina at Chapel Hill, who has been studying the impact of dietary flavonoids on breast cancer.


        [Presentation title: A Prospective Analysis of Dietary Flavonoid Intake and Epithelial Ovarian Cancer Incidence. Abstract 4013]



        E-Mail this DGDispatch to a colleague   To print, use this version






        All contents Copyright (c) 1995-2008 Doctor's Guide Publishing Limited. All rights reserved.



        The NTK initiative. Physicians helping physicians identify Need-To-Know science
           Feedback
        Please rate this article: Strongly DISAGREE...Strongly AGREE NTK logo
        Question 1 - Physicians need to become aware of this information as soon as possible. Question 2 - This information is likely to have an impact on the way physicians practice medicine.
        1
        2
        3
        4
        5
        6
        7
        Send